Company Performance Metrics
Syntacoll is the manufacturing division of Innocoll, Inc. and produces clinical
supply or commercial product to its marketing partners and to Innocoll’s two other divisions, Innocoll Technologies and Innocoll Pharmaceuticals. Using proprietary manufacturing processes, Syntacoll converts raw collagen material and incorporates medicinal compounds
yielding finished pharmaceutical product in the form of a sponge or membrane. This system forms the basis of Innocoll’s lead collagen-based technology, CollaRx. The sponge or membrane product format is a unique way to locally deliver a wide variety of medicinal compounds and is fully biodegradable and resorbable. The sponge and the membrane formats can be implanted at the time of surgery
or applied topically to a chronic, acute or traumatic wound. Delivering drug locally to the site of action has a number of benefits, including the safe delivery of higher doses than could be achieved through systemic routes and avoidance of systemic side effects.
